As the biopharma industry explores the potential of artificial intelligence, use cases are quickly emerging. Companies are already looking to use generative AI—think ChatGPT—to optimize pharma R&D, from target discovery to drug development to regulatory approval to commercialization and postmarket pharmacovigilance.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,